Mastering Good Documentation Practice (GDP) | Persimmon Engineering
Austin Chuang • May 6, 2026
The Ultimate Guide to Good Documentation Practice (GDP)
Source URL: https://www.gmp-compliance.org/gmp-news/what-is-meant-by-good-documentation-practice
Mastering Compliance Through Precise Documentation
In the biopharmaceutical landscape, documentation serves as the backbone of the Quality Management System (QMS). According to regulatory authorities, if a procedure is not meticulously documented, it officially did not occur. This step-by-step guide demystifies Good Documentation Practice (GDP), transforming compliance burdens into streamlined, foolproof systems that protect product quality, ensure batch traceability, and minimize compliance risks across your entire facility.
1. Establishing Quality and Traceability Foundations
Traceability is your ultimate safety net. In the event of a product recall or quality issue, the documented steps must make the entire manufacturing process of a batch perfectly traceable—from raw materials to involved personnel. It serves as irrefutable proof of compliance and protects your organization legally.
The EU GMP guidelines clearly mandate that documentation is an indispensable component of the overarching quality system. This satisfies proof of legal protection during audits.
Deploy structured batch records and SOPs that eliminate ambiguity. Ensure that every phase of manufacturing—from compounding to final release—is linked through a secure identifier system, empowering rapid investigations.
2. Implementing ALCOA+ for Data Integrity
Data must be flawless. Without impeccable data integrity, process parameters cannot be validated. High-quality data is the primary driver of knowledge management, allowing processes to be effectively reproduced and continuously improved.
The core framework is the ALCOA principle, which strictly requires all data to be attributable, legible, timely, original, and accurate.
Enforce "timely recording" directly at the workstation. Standardize timestamps, mandate clear signatures, and prohibit delayed batch entries. All corrections must be signed, dated, and accompanied by a justification without obscuring the original text.
3. Defining Core Document Frameworks
Lack of clarity invites deviations. Missing critical information, such as exact tolerance limits or process parameters, can directly trigger serious regulatory complaints.
Under the German Medicines Act (AMG), the AMWHV, and FDA 21 CFR Part 211, facilities are legally obligated to introduce an airtight documentation system with stringent requirements for completeness and immutability.
Structure your documentation hierarchy strictly. Develop detailed instructions (SOPs, manufacturing guidelines) in advance, ensure they are approved before execution, and maintain raw data precisely to serve as the baseline for all subsequent analyses.
4. Securing Electronic & Hybrid Systems
Digital records require active defense. Transitioning from paper to electronic (or hybrid) documentation increases efficiency but demands severe control mechanisms against data loss and unauthorized tampering.
Electronic systems trigger specific regulatory burdens: formal validation of the computerized systems, robust protection against data loss, ensuring perpetual legibility, and the strict implementation of electronic signatures.
Execute comprehensive Computerized System Validation (CSV). Configure granular audit trails, implement automated data backups, and utilize 21 CFR Part 11 compliant electronic signatures for all approvals and releases.
5. Executing In-Process and Deviation Logging
The true state of manufacturing is defined by its deviations. Documenting the "happy path" is insufficient. Real process control relies on capturing in-process control data, tolerance limits, and precisely assessing deviations.
EU GMP and FDA mandates dictate that a complete record is required for each batch, and this absolutely must include full documentation of all deviations alongside their specific assessments.
Integrate mandatory entry fields for out-of-specification (OOS) results directly into the batch record workflow. Ensure that personnel adhere strictly to instructions and document immediate deviations before continuing production.
6. Document Archiving and Lifecycle Control
Compliance doesn't end at product release. Legal protection and organizational learning require historical data to be rapidly accessible. Without secure archiving, companies lose their marketing authorizations or face crippling legal disputes.
Regulations impose strict retention requirements: documents must be securely archived in full, clearly allocated, and kept for stringently defined timeframes without any subsequent, non-traceable changes.
Implement a centralized document management architecture. Establish robust dating, versioning, and regular updating protocols. Ensure physical and digital archives map precisely to the defined timeframes established by international health authorities.
Original Source Content
What is meant by Good Documentation Practice?
Principles of GMP-compliant documentation
Documentation fulfils several key functions within the GMP environment and is an indispensable component of quality assurance.
A primary objective is to ensure product quality. GMP-compliant documentation demonstrates that a medicinal product has been manufactured in accordance with the approved specifications and legal requirements. Without this evidence, neither compliance with regulatory requirements could be verified nor the quality of a product substantiated.
Another key aspect is traceability. The documented steps must make the entire manufacturing process of a batch traceable - from the raw materials used and process parameters right through to the personnel involved. This traceability is particularly crucial in the event of quality issues or product recalls. It enables the systematic monitoring, control and evaluation of all quality-relevant processes. The EU GMP guidelines therefore describe documentation as an essential component of the quality system.
Legal protection also plays an important role. Documents serve as evidence for regulatory authorities. In the event of a dispute, only complete documentation can prove that processes were carried out correctly.
Another key point is data integrity. The ALCOA principle requires that data must be attributable, legible, timely, original and accurate. GMP-compliant documentation ensures that these requirements are met.
Furthermore, documentation supports knowledge management by enabling processes to be documented, made reproducible and continuously improved.
In summary, documentation is necessary for quality, traceability, legal certainty, data integrity and organisational learning.
Where do the specifications/requirements come from?
The requirements for GMP-compliant documentation stem from various regulatory and organisational sources. The most important foundations are statutory regulations. In Germany, these are:
- the German Medicines Act (AMG)
- the Ordinance on the Manufacture of Medicinal Products and Active Substances (AMWHV)
These oblige companies to introduce a documentation system and define fundamental requirements such as completeness, legibility and protection against tampering.
The overarching, Europe-wide guideline is the EU GMP Guide. This specifies the legal requirements and describes in detail the documentation requirements, e.g. in Chapter 4.
In addition, national authorities such as the German ZLG (Zentralstelle der Länder für Gesundheitsschutz bei Arzneimitteln und Medizinprodukten - Central Agency of the Federal States for Health Protection in relation to Medicinal Products and Medical Devices) provide practical guidance on interpretation in the form of procedural instructions and aide-mémoires.
At an international level, FDA regulations play a significant role, particularly 21 CFR Part 211. These contain detailed requirements for production controls and reports. In addition, there are international guidelines, such as those from the ICH (International Council for Harmonisation), which define harmonised standards worldwide.
Finally, specific requirements also originate from internal company sources, in particular:
- Marketing authorisation dossiers
- Development data
- Specifications
This results in an interplay of legal, regulatory and internal requirements.
What information/requirements are necessary?
The documentation comprises various document types and contents defined in the EU GMP guidelines.
The most important document types include:
- Instructions (e.g. manufacturing instructions)
- SOPs (Standard Operating Procedures)
- Specifications
- Records (e.g. manufacturing records)
- Reports and certificates of analysis
Manufacturing instructions, which specify how a product is manufactured, play a central role. These must be drawn up in advance, approved, checked and strictly adhered to. Equally important are manufacturing records, in which the actual execution is documented. A complete record is required for each batch, including all deviations. Raw data is another important component. It serves as the basis for all analyses and must be fully retained or stored.
The documentation must also include the following:
- Process parameters and target values
- Tolerance limits
- Results of in-process controls
- Deviations and their assessment
- Responsibilities and signatures
Missing information - such as tolerance limits - can lead to serious complaints.
In addition, details regarding test methods and validation or stability data are required. Approvals and releases must also be documented.
Finally, retention requirements must be observed: documents must be archived in full and for defined periods.
How is documentation carried out and what must be observed?
The practical implementation of documentation is subject to the rules of good documentation practice.
Key requirements are:
- Legibility
- Traceability
- Completeness
- Timely recording
- Immutability
These requirements ensure that data is reliable and verifiable.
Documentation may be carried out in paper form, electronically or in a hybrid format. In all cases, suitable control mechanisms must be in place. Additional requirements apply to electronic systems, such as:
- Validation of the systems
- Protection against data loss
- Ensuring legibility
- Use of electronic signatures
The creation of documents is also regulated:
- Clear and unambiguous content
- Approval by authorised persons
- Dating and versioning
- Regular updating
The following aspects are crucial during implementation:
- Strict adherence to instructions
- Immediate and complete documentation
- Documentation of all deviations
- No subsequent, non-traceable changes
Entries must not be rendered illegible, and changes must remain transparent.
The retention of documents requires:
- Secure archiving
- Clear allocation
- Compliance with defined timeframes
Conclusion
In the GMP environment, documentation is a central component of quality assurance and regulatory compliance. It serves not only to provide evidence, but also for process control, risk minimisation and knowledge retention.
The requirements arise from a complex interplay of laws, guidelines and internal regulations. Content and implementation are clearly regulated and must be strictly adhered to.
Errors or gaps in documentation can have serious consequences, such as complaints from regulatory authorities or the loss of marketing authorisations. Therefore, the following principle applies in the pharmaceutical sector: 'What is not documented is considered not to be done.'
Elevate Your Facility's Compliance Standard
At Persimmon Engineering, we specialize in designing FDA/PIC/S compliant systems and seamless Computerized System Validations (CSV). Don't let documentation gaps risk your next regulatory audit.
Consult with Our Experts Today